Summary
In the adrenocortical carcinoma cell, in contrast to normal isolated adrenal cells, 10 to 50 µunits of ACTH do not raise the level of adenosine cyclic 3′:5′-monophosphate (cyclic AMP), protein kinase activity, and steroidogenesis. This indicates a lesion in the tumor adenylate cyclase system.
Two-tenths to 10 mm cyclic AMP and guanosine cyclic 3′:5′-monophosphate (cyclic GMP), which stimulate steroidogenesis in a normal cell, activate protein kinase activity in a concentration-response manner without any detectable rise in steroidogenesis in the adrenocortical carcinoma cell. Cycloheximide and actinomycin D do not inhibit the stimulation of the phosphorylation. These results suggest that the tumor cyclic nucleotide-dependent protein kinase activity is unrelated to steroidogenesis and is also not under the transcriptional or translational control steps.
Curiously, µm concentrations of cyclic AMP, in contrast to cyclic GMP, stimulate protein kinase activity. In a normal cell, both cyclic AMP and cyclic GMP, in this concentration range, stimulate protein kinase without an increase in steroidogenesis. It is therefore proposed that, in contrast to the normal cell, there is an additional defect in cyclic GMP-dependent protein kinase.
This investigation was supported by Grants CA-16091 from the National Cancer Institute DRG-1237 from the Damon Runyon Memorial Fund for Cancer Research.